~~<i id='9186F76193'><strike id='9186F76193'><tt id='9186F76193'><pre id='9186F76193'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

comprehensive

author：hotspot 2025-09-30 07:27:42 - browse：57

Senate health committee Chair Bernie Sanders — Sen. Berne Sanders (I-Vt.) Kevin Dietsch/Getty Images

WASHINGTON — Sen. Bernie Sanders (I-Vt.) has a new corporate target: the food industry.

Sanders held a hearing today on diabetes that implicated both the food and drug industries in what the American Diabetes Association estimates is a $413 billion annual cost to the health care system. That’s up 27% over the past six years, he said, and he warned that new weight loss drugs could send health care spending to the stratosphere.

But the food industry received more attention, especially from Sanders, than the drugmakers and drug middlemen.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Ambulance rides for just $100? Advisers want major billing fixes

entertainment

focus

entertainment

hotspot

knowledge

Walmartseemspoisedtoincreaseitshealthcarefootprintbybuyingvalue-basedseniorcarecompanyChenMed.JoeRae

WSS

A common UTI test for kids haunts adults as a traumatic 'nightmare'

Pig kidney works a record two months in donated body

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

Diverse clinical trials: Why aren’t we there yet?

FDA approves Recor Medical high blood pressure device

Hospitals consider fixing cancer drug shortages on their own

focus

comprehensive

entertainment

Jerome Adams on the need for new antivirals for Covid

New weight loss drugs vying to be the next Wegovy or Mounjaro

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

FDA approves Recor Medical high blood pressure device

Medicare details structure of new drug price negotiation program

Victims of gun violence feel impacts long after bullet wound

Anesthesiologist group: stop taking Ozempic before surgery

White House touts steps to stem shortages of cancer treatments

Activists slam private health insurers over coverage restrictions

Biotech incubator Curie.Bio graduates its first startup

focus

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

Medicare will require more price transparency from hospitals

The new shift in health care is toward less care

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

Long Covid needs a new name — and a new frame

White House touts steps to stem shortages of cancer treatments

entertainment

entertainment

hotspot

knowledge